Russell Kevin Klass - Nov 7, 2023 Form 4 Insider Report for Zomedica Corp. (ZOM)

Role
Vice President of Sales
Signature
/s/ Russell Kevin Klass
Stock symbol
ZOM
Transactions as of
Nov 7, 2023
Transactions value $
$0
Form type
4
Date filed
11/14/2023, 04:31 PM
Previous filing
Nov 9, 2023
Next filing
Jun 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZOM Option to Buy Common Stock Award $0 +2M $0.00 2M Nov 7, 2023 Common Stock 2M $0.20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest annually in four equal installments commencing on November 7, 2023.
F2 This amendment to the Form 4 filed on November 9, 2023 is being filed to correct the exercise price. An administrative rounding error was made in the initial report, and the correct exercise price is $.20 per share.